TelyRx Holdings Inc. is facing a drop in its stock price, which has raised concerns among investors.
Today, TelyRx Holdings Inc. (TELY.TO) saw its stock price fall by 3.33%, closing at CA$2.61. This decline is part of a larger trend that has left investors questioning the company’s performance and future outlook.
Advertisement
Get up to $2,000 cash back
Open and fund a new Qtrade account with promo code SPRING26. Offer ends July 31, 2026.
TelyRx Holdings Inc.
TELY.TO
TELY.TO
TelyRx Holdings Inc.
WealthAwesomeMarket cap
$73.09M
52W high
$4.25
52W low
$2.00
1W change
+10.20%
Analyst Price Targets
Based on analyst covering TELY
Wall Street analysts forecast TELY stock price to rise 122.2% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$6.00
+122.2% Upside
Current Price
C$2.70
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on TELY's historical volatility
30-Day Vol
102.6%
Annualized
90-Day Vol
97.8%
Annualized
Trend (90d)
-50.0%
Annualized drift
90d Mean
C$2.26
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$2.54 | C$1.79 – C$3.62 |
| 60 trading days | C$2.40 | C$1.45 – C$3.95 |
| 90 trading days | C$2.26 | C$1.22 – C$4.17 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Investor takeaway: Keep an eye on TelyRx's financial health and market positioning, especially after today’s significant drop.
TelyRx's stock drops 3.33% today
With a market cap of CA$73,091,416, TelyRx's current financial situation raises questions about its valuation compared to its growth potential.
Bull case
Despite the recent decline, TelyRx has shown impressive revenue growth in previous quarters. This could indicate a chance for recovery if the company continues to leverage its digital pharmacy services effectively.
Bear case
The recent stock price drop reflects investor worries about TelyRx's profitability, highlighted by its negative profit margin of -18.17%. Without a clear path to becoming profitable, further declines may be likely.
Current Market Performance
TelyRx Holdings Inc.'s stock has dropped by 3.33% today, signaling growing unease among investors. This decline comes even after the company announced revenue growth, which may not be enough to ease concerns about its profitability.
Financial Health Overview
With a market cap of CA$73,091,416 and a negative profit margin of -18.17%, TelyRx's financial metrics suggest challenges ahead. Investors should keep these factors in mind when assessing the stock's recovery potential.
Looking Ahead
As TelyRx works on its growth strategy, investors will be closely watching for updates on financial performance and market positioning. The company’s ability to convert revenue growth into profitability will be crucial for restoring investor confidence.
Advertisement
